Transcend: девять шагов на пути к вечной жизни - Рэй Курцвейл

7. Leger D., Laudon M., Zisapel N. (2004) Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy // Am. J. Med. 116:91–95.

8. The Writing Group for the WHI Investigators (2002) Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results of the Women’s Health Initiative randomized controlled trial // JAMA 288 (3): 321–333.

9. The Women’s Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative randomized controlled trial // JAMA 291: 1701–1712.

10. Rossouw J. E., Prentice R. L., Manson J. E., Wu L., Barad D., Barnabei V. M., Ko M., LaCroix A. Z., et al. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause // JAMA 297: 1465–1477.

11. Fournier A., Berrino F., Riboli E., Avenel V., and Clavel-Chapelon F. (2005). Риск развития рака молочной железы в связи с различными видами заместительной гормональной терапии в когорте E3N-EPIC // Проблемы репродукции. М.: Медиа Сфера, № 4 (2005).

12. Rudman D., Drinka P. J., Wilson C. R., Mattson D. E., Scherman F., Cuisinier M. C., Schultz S. (1994) Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men // Clin Endo 40: 653–661.

13. Stephenson K., Price C., Kurdowska A., Neuenschwander P., Stephenson J., Pinson B., Stephenson D., Alfred D., Krupa A., Mahoney D., Zava D., and Bevan M. (2004) Topical progesterone cream does not increase thrombotic and inflammatory factors in postmenopausal women // ASH Annual Meeting Abstracts 104: 5318.

1. Das UN (2006) Exercise and inflammation // The Euro Heart J. 27 (11): 1385.

2. Fenech M., Aitken C., Rinaldi J. (1998) Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults // Carcinogenesis 19 (7): 1163–1171.

1. American Cancer Society, “Cancer Facts and Figures,” cancer.org/docroot/stt/stt_0.asp.

2. American Cancer Society, “Costs of Cancer,” cancer.org/docroot/MIT/content/MIT_3_2X_Costs_of_Cancer.asp.

3. Key T. J., Schatzkin A., Willett W. C., Allen N. E., Spencer E. A., Travis R. C. (2004) Diet, nutrition and the prevention of cancer // Pub Health Nutr Feb 7 (1A): 187–200.

4. Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. (2003) Adherence to a Mediterranean diet and survival in a Greek population // N Engl J. Med 348 (26): 2599–2608.

5. Dominique M. S., Simin L., Giovannucci E., Willett W. C., Graham C. A., Fuchs C. S. (2002) Dietary sugar, glycemic load and pancreatic cancer risk in a prospective study // Natl Can Jnsf 94 (17): 1293–1300.

6. Higginbotham S., Zhang Z. F., Lee I. M., Cook N., Giovannucci E., Buring J. E., Liu S. (2004) Dietary glycemic load and risk of colorectal cancer in the Women’s Health Study // Natl Can Inst 96 (3): 229–233.

7. Calle E. E., Rodrigue C., Walker-Thurmond K., Thun M. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults // NEJM 348 (17): 1625–1638.

8. Zheng Q. S., Zheng R. L. (2002) Effects of ascorbic acid and sodium selenite on growth and redifferentiation in human hepatoma cells and its mechanisms // Pharmazie 57 (4): 265–269.

9. Duffield-Lillico A. J., Reid M. E., Turnbull B. W., Combs G. F., Slate E. H., Fischbach L. A., Marshall J. R., Clark L. C. (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial // Cancer Epidemiol Biomarkers Prev 11: 630–639.

10. Lappe J. M., Travers-Gustafson D. T., Davies K. M., Recker R. R., Heaney R. P. (2007) Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial // Amer J. of Clin Nutr 85 (6): 1586–1591.

11. Eichholzer M., Luthy J., Moser U., Fowler B. (2001) Folate and the risk of colorectal, breast and cervix cancer: The epidemiological evidence // Swiss Med Wkly 131: 539–54.

1. Kathiresan S., Melander O., Anevski D., Guiducci C., Burtt N. P., Roos C., Hirschhorn J. N., Berglund G., Hedblad B., Groop L., Altshuler D. M., Newton-Cheh C., Orho-Melander M. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events // N Engl J. Med. 358 (12): 1240–1249.

2. Love-Gregory L., Sherva R., Sun L., Wasson J., Schappe T., Doria A., Rao D. C., Hunt S. C., Klein S., Neuman R. J., Permutt M. A., Abumrad N. A. (2008) Variants in CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol // Human Molecular Genetics 17 (11): 1695–1704.

1. National Center for Health Statistics, “Deaths – leading causes,” cdc.gov/nchs/FASTATS/lcod.htm.

1. Holmes T., Rahe R. (1967) The social readjustment rating scale // Psychosom Res 11 (2): 213–218.

2. Weber G. (2004) Weber G. (2004) Lost time: Vacation days go unused despite more liberal time-off policies. Workforce Man. Dec: 66–67 workforce.com/section/02/feature/23/89/82/index.html.

3. Haskell C. F., Kennedy D. O., Milne A. L., Wesnes K. A., Scholey A. B. (2008) The effects of 1-the-anine, caffeine and their combination on cognition and mood // Bio Psych 77 (2): 113–122.

4. Zaret B. L., Moser M., Cohen L. S. (1992) Yale University School of Medicine Heart Book med.yale.edu/library/heartbk/p.97.

5. Moyer C. A., Rounds J., Hannum J. W. (2004) A meta-analysis of massage therapy research // Psych Bull 130 (1): 3–18.

6. Benson H., Beary J. F., Carol M. P. (1974) The relaxation response // Psychiatry 37 (l): 37–46.

7. Klag M. J, Wang N. Y., Meoni L. A., Brancati F. L., Cooper L. A., Liang K. Y., Young J. H., Ford D. E. (2002) Coffee intake and risk of hypertension: The Johns Hopkins precursors study // Arch Intern Med 162 (6): 657–662.

8. El Yacoubi M., Ledent C., Parmentier M., Costentin J., Vaugeois J.M. (2000) The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists // Psychopharmacology (Berl) 148 (2): 153–163.

9. Haskell C. F., Kennedy D. O., Milne A. L., Wesnes K. A., Scholey A. B. (2007) The effects of L-theanine, caffeine and their combination on cognition and mood // Biol Psychol 77 (2): 113–122.

1. van Dam R. M., Li T., Spiegelman D., Franco O. H., Hu F. B. (2008) Combined impact of lifestyle factors on mortality: Prospective cohort study in US women // BMJ 337: al 440.

2. Kosters J. P., Gotzsche P. C. (2003) Regular self-examination or clinical examination for early detection of breast cancer // Cochrane Database of Systematic Reviews 2: CD003373. DOI: 10.1002/14651858.CD003373.

1. O’Keefe J. H., Gheewala N. M., O’Keefe J. O. Стратегия правильного питания в целях улучшения показателей постпрандиальных уровней глюкозы и липидов, устранения воспаления и улучшения состояния сердечно-сосудистой системы // JACC, Т. 2 № 4, 2009, С. 164–170.

2. MedWireNews, September 28, 2007, “Alcohol amount, not type, affects breast cancer risk”.

3. Sesso H. D., Paffenbarger Jr. R. S., Lee I. M. (2001) Alcohol consumption and risk of prostate cancer: The Harvard Alumni Health Study // Int J of Epi 30: 749–755.

4. Johnston C. S., Kim C. M., Buller A. J. (2004) Vinegar improves insulin sensitivity to a high-carbohydrate meal in subjects with insulin resistance or type 2 diabetes // Diabetes Care 27: 281–282.

1. Ames B. N., Wakimoto P. (2002) Are vitamin and mineral deficiencies a major cancer risk? // Nature Reviews Cancer 2: 694–704.

2. University Medical Center Rotterdam, “The Rotterdam Study,” epib.nl/ergo.htm.

3. Losonczy K. G., Harris T. B., Havlik R. J. (1996) Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies in the Elderly // Am J. Clin Nutr 64 (2): 190–196.

4. Li H., Stampfer M. J., Giovannucci E. L., Morris J. S., Willett W. C., Gaziano J.M., Ma J. (2004) A prospective study of plasma selenium levels and prostate cancer risk // J. Natl Cancer Inst 96 (9): 696–703.

5. Miller E. R., Pastor-Barriuso R., Dalai D., Riemersma R. A., Appel L. J., Guallar E. (2005) Metaanalysis: High-dosage vitamin E supplementation may increase all-cause mortality // Ann Intern Med 142: 37–46.

6. Ames B. N., Elson-Schwab I., Silver E. A. (2002) High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): Relevance to genetic disease and polymorphisms // Amer J. of Clin Nut 75 (4): 616–658.

7. Chen Q., Espey M. G., Sun A. Y., Pooput C., Kirk K. L., Krishna M. C., Khosh D. B., Drisko J., Levine M. (2008) Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice // Pro c Natl Acad Sci USA. 105 (32): 11105–11109.

8. Bjelakovic G., Nikolova D., Gluud L. L., Simonetti R. G., Gluud C. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis // JAMA 297 (8): 842–857.

9. Willett W. C., Stampfer M. J. (2001) Clinical practice. What vitamins should I be taking, doctor? // N Engl J. Med 345 (25): 1819–1824.

10. Portakal O., Ozkaya O., Erden Inal M., Bozan B., Kosan M., Sayek I. (2000) Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients // Clin Biochem 33 (4): 279–284.

11. Bagchi D., Bagchi M., Stohs S., Ray S. D., Sen C. K., Preuss H. G. (2002) Cellular protection with proanthocyanidins derived from grape seeds // Ann NY Acad Sci 957: 260–270.

12. Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A., Prabhu V. V., Allard J. S., Lopez-Lluch G., Lewis K., Pistell P. J., Poosala S., Becker K. G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K. W., Spencer R. G., Lakatta E. G., Le Couteur D., Shaw R. J., Navas P., Puigserver P., Ingram D. K., de Cabo R., Sinclair D. A. (2006) Resveratrol improves health and survival of mice on a high-calorie diet // Nature 444 (7117): 337–342.

1. National Institute of Diabetes and Digestive and Kidney Disease, Statistics Related to Overweight and Obesity, win.niddk.nih.gov/statistics/index.htm.

2. Cummings D. E., Weigle D. S., Frayo R. S., Breen P. A., Ma M. K., Dellinger P., Purnell J. Q. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery // NEJM 346 (21): 1623–1630.

3. Allison D. B., Miller R. A., Austad S. N., Bouchard C., Leibel R., Klebanov S., Johnson T., Harrison D. E. (2001) Genetic variability in responses to caloric restriction in animals and in regulation of metabolism and obesity in humans // Gerontol A Biol Sci Med Sci 56 Spec № 1: 55–65.

4. Masoro E. J., Yu B. P., Bertrand H. A. (1982) Action of food restriction in delaying the aging process // Proc Natl Acad Sci USA 79 (13): 4239–4241.

1. Kokkinos P., Myers J., Kokkinos J. P., Pittaras A., Narayan P., Manolis A., Karasik P., Green-berg M., Papademetriou V., Singh S. (2007) Exercise capacity and mortality in black and white men // Circulation 117: 589–591.

2. Cherkas L. F., Hunkin J. L., Kato B. S., Richards B., Gardner J. P., Surdulescu G. L., Kimura M., Lu X., Spector T. D., Aviv A. (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Int Med 168 (2): 154–158.

3. Reeves N. D., Narici M. V., Maganaris C. N. (2006) Myotendinous plasticity to ageing and resistance exercise in humans // Exp Physiol 91 (3): 483–498.

4. Kraemer W. J., Hakkinen K., Newton R. U., Nindl B. C., Volek J. S., McCormick M., Gotshalk L. A., Gordon S. E., Fleck S. J., Campbell W. W., Putukian M., Evans W. J. (1999) Effects of heavy-resistance training on hormonal response patterns in younger vs. older men // Appl Physiol 87 (3): 982–92.5.

5. Cornelissen V. A., Fagard R. H. (2005) Effect of resistance training on resting blood pressure: A meta-analysis of randomized controlled trials. J. Hypertens 23 (2): 251–259.

6. Henriksson J. (1995) Influence of exercise on insulin sensitivity // Cardiovasc Risk 2 (4): 303–309.

7. Engelke K., Kemmler W., Lauber D., Beeskow C., Pintag R., Kalender W. A. (2006) Exercise maintains bone density at spine and hip EFOPS: A 3-year longitudinal study in early postmenopausal women // Osteoporosis Int 17 (1): 133–142.

1. De Grey A., Rae M. (2007) Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime. New York: St. Martins Press.

2. Kurzweil, R. (2005) The Singularity Is Near; When Humans TRANSCEND Biology. New York: Viking.

1. Sundell J. (2004) On the history of indoor air quality and health // Indoor Air 4: 14 Suppl 7: 51–58.

2. Yoder J., Roberts V., Craun G. F., Hill V., Hicks L. A., Alexander N. T., Radke V., Calderon R. L., Hlavsa M. C., Beach M. J., Roy S. L.; Centers for Disease Control and Prevention (CDC) (2008) Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking – United States, 2005–2006 // MMWR Sur-veill Summ 57 (9): 39–62.

3. Hyland G. J. (2000) Physics and biology of mobile telephony // Lancet 356 (9244): 1833–1836.

4. Beyersmann D., Hartwig A. (2008) Carcinogenic metal compounds: Recent insight into molecular and cellular mechanisms // Arch Toxicol 82 (8): 493–512.